Athira Pharma GAAP EPS of -$0.80 misses by $0.27
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Health & Medicine
Arm Fat Overtakes All Other Concerns as Top Reason Singapore Women Seek Body Sculpting Consultations, Clinic Data Shows
Amaris B. Clinic's first-half 2026 enquiry figures show arm-related concerns accounted for 41.4% of all body-sculpting enquiries from women, with nearly half of those enquiries coming from women in…
Forschung: Astra-Zeneca stoppt Studie zu Krebsmittel
Der britische Pharmakonzern beendet eine wichtige Lungenkrebsstudie mit dem experimentellen Wirkstoff Volrustomig. Zugleich meldet der Konzern Fortschritte mit anderen Krebsmedikamenten.
The No Surprises Act could be a shock to the U.S. health care system
If physicians' fees rise and insurers face mounting arbitration costs, consumers will ultimately be on the hook.
Health Ministry creates 607 posts, approves RM1.57bil for Sabah healthcare
KOTA KINABALU: The Health Ministry has created 607 new positions in Sabah as of Aug 1 this year to ensure state healthcare facilities operate at optimal capacity.
India's healthcare ambition goes beyond affordable treatment
India’s healthcare story over the past eight decades has been one of remarkable transformation, from tackling shortages in access and infrastructure to emerging as a global powerhouse in…
What’s driving men to get penis fillers, despite the risks?
Jason didn’t want a “Coke can” – that’s the nickname for a penis that has been enlarged with so much filler it resembles a stubby drink can.